Literature DB >> 19462665

Reversible substrate binding at copper centers in neutral copper(I) carbene complexes derived from bis(3-tert-butylimidazole-2-ylidene)methane.

Igor V Shishkov1, Frank Rominger, Peter Hofmann.   

Abstract

Deprotonation of the CH2-bridged bis-imidazolium salt [H2(BIM(tBu))]Br2 followed by reaction with CuBr afforded polymeric [(BIM(tBu))2(CuBr)2]n (3), where BIM(tBu) = bis(3-tert-butylimidazole-2-ylidene)methane. In the solid state, compound 3 is an organometallic polymer with an unusual (-L-Cu-(micro-Br)2-Cu-L-)n type of bonding. The reaction of 3 with nitrogen bases N-tert-butylimidazole or piperidine splits the polymer and afforded the corresponding mononuclear amine adducts [(BIM(tBu))2(CuBr)2(amine)] (6 and 7, respectively). Their molecular structures revealed a unique bonding pattern, which has no precedents in copper-NHC coordination chemistry. The amine binding energies in 6 or 7 of 0.7-7.7 kcal mol(-1), calculated by DFT methods, are consistent with an experimentally observed ligand exchange in solution, fast on the NMR time scale.

Entities:  

Year:  2009        PMID: 19462665     DOI: 10.1039/b813790k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) by Functionalized NHC-Based Polynuclear Catalysts: Scope and Mechanistic Insights.

Authors:  Miguel González-Lainez; Miguel Gallegos; Julen Munarriz; Ramón Azpiroz; Vincenzo Passarelli; M Victoria Jiménez; Jesús J Pérez-Torrente
Journal:  Organometallics       Date:  2022-07-15       Impact factor: 3.837

2.  Copper diamidocarbene complexes: characterization of monomeric to tetrameric species.

Authors:  Lee R Collins; John P Lowe; Mary F Mahon; Rebecca C Poulten; Michael K Whittlesey
Journal:  Inorg Chem       Date:  2014-02-11       Impact factor: 5.165

3.  Organometallic chemistry.

Authors:  Bernd F Straub; Rolf Gleiter; Claudia Meier; Lutz H Gade
Journal:  Beilstein J Org Chem       Date:  2016-10-19       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.